PubHawk
Obes Sci Pract April 2023 PMID 37034559

A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder.

Kelly C Allison, Ariana M Chao, Maija B Bruzas, Courtney McCuen-Wurst, Elizabeth Jones, Cooper McAllister, Kathryn Gruber, Robert I Berkowitz, Thomas A Wadden, Jena S Tronieri

Full text PDF Download social card

Mentions

8
Peak: 1 in Apr 2023
across 4 sources since Apr 2023

Extended reach

167
potential audience

Total likes

0

Video views

44

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

  • News4 articles
  • Blogs2 articles
  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions reflect cautious optimism, with comments like acknowledging the promising results in reducing binge episodes and weight loss, but also noting the study's limitations and need for further research. Words like 'promising,' 'needs confirmation,' and references to 'further research' reveal a balanced tone where the potential impact is recognized but not overstated.

AgreementModerate agreement

Most discussions seem to agree that the study presents promising signs for liraglutide's potential in treating BED, though some highlight the need for further research.

InterestModerate interest

Participants show moderate curiosity, often discussing weight loss and reduction in binge episodes, but not overwhelmingly so.

EngagementModerate engagement

The conversations include engagement with methodological aspects, such as the study’s limitations, and implications for future treatments, indicating some depth.

ImpactNeutral impact

The overall influence on current treatment practices appears limited, as respondents acknowledge the preliminary nature and need for additional confirmation.

Abstract in brief

  • This 17-week pilot study tested whether liraglutide, a medication for diabetes that acts on GLP-1 receptors, can reduce binge eating episodes and promote weight loss in adults with binge eating disorder (BED).
  • Participants taking liraglutide showed a greater decrease in binge episodes and more significant weight loss compared to those on placebo, though binge remission rates did not differ significantly between groups.
  • The study faced a limitation due to a pharmacy dispensing error, and further research is needed to confirm liraglutide's effectiveness for BED treatment.]
Read the full abstract

Top posts

Most liked on X and Bluesky
CHOP Publication Bot
@chop_pubs · X

Kelly C Allison: A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder https://t.co/OOxLZ6yw7N

Apr 10, 2023 · 124 followers View post →

All mentions

CHOP Publication Bot
@chop_pubs · X

Kelly C Allison: A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder https://t.co/OOxLZ6yw7N

Apr 10, 2023 · 124 followers View post →